14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Monday, 6th May 2024 ZNTL stock ended at $11.72. This is 0.0854% more than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 5.63% from a day low at $11.55 to a day high of $12.20.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Zentalis Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Nov 03, 2023 $16.90 $18.02 $16.73 $17.88 971 574
Nov 02, 2023 $16.69 $17.07 $16.43 $16.60 673 743
Nov 01, 2023 $16.27 $16.81 $16.27 $16.35 582 473
Oct 31, 2023 $16.04 $16.51 $15.93 $16.36 504 805
Oct 30, 2023 $16.28 $16.80 $15.95 $16.00 949 499
Oct 27, 2023 $16.14 $16.34 $15.63 $16.20 1 055 907
Oct 26, 2023 $16.00 $16.34 $15.78 $16.03 580 208
Oct 25, 2023 $16.29 $16.29 $15.77 $16.00 715 548
Oct 24, 2023 $16.94 $17.45 $16.61 $16.67 1 171 182
Oct 23, 2023 $17.81 $17.81 $16.17 $16.56 991 861
Oct 20, 2023 $18.20 $18.32 $17.65 $17.95 966 394
Oct 19, 2023 $18.21 $18.21 $17.60 $18.00 1 089 427
Oct 18, 2023 $18.61 $18.85 $18.09 $18.21 522 326
Oct 17, 2023 $18.47 $19.14 $18.47 $18.75 638 621
Oct 16, 2023 $19.12 $19.13 $18.21 $18.77 560 612
Oct 13, 2023 $18.95 $19.02 $18.50 $18.94 725 425
Oct 12, 2023 $19.13 $19.13 $18.32 $18.75 1 922 149
Oct 11, 2023 $19.33 $21.34 $18.97 $19.18 690 141
Oct 10, 2023 $19.42 $19.89 $19.31 $19.34 663 863
Oct 09, 2023 $19.69 $19.70 $19.03 $19.41 605 557
Oct 06, 2023 $19.80 $20.60 $19.68 $20.06 422 126
Oct 05, 2023 $19.90 $20.33 $19.36 $20.13 627 047
Oct 04, 2023 $19.43 $19.93 $18.91 $19.91 675 675
Oct 03, 2023 $19.57 $20.15 $19.06 $19.31 807 929
Oct 02, 2023 $19.90 $20.26 $19.45 $19.86 1 207 137
Click to get the best stock tips daily for free!

About Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; Phase 1/2 clinical trial for the treatment of advanced solid tumors as a monotherapy and in an ... ZNTL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT